# Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

> **NCT01897402** · PHASE2 · COMPLETED · sponsor: **JN-International Medical Corporation** · enrollment: 525 (actual)

## Conditions studied

- Meningococcal Meningitis
- Meningococcal Infections

## Interventions

- **BIOLOGICAL:** Test Vaccine
- **BIOLOGICAL:** US Licensed Vaccine

## Key facts

- **NCT ID:** NCT01897402
- **Lead sponsor:** JN-International Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-12
- **Target enrollment:** 525 (ACTUAL)
- **Last updated:** 2015-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01897402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01897402, "Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01897402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*